Yu dɔn gɛt bak di kɔlɔstrel lɛvɛl we dɔn go ɔp smɔl ɛn di dɔktɔ dɔn gi yu mɛrɛsin? We sɔm pipul dɛn de tek di statin drɔgs we dɛn kin gi dɛn, i nɔ kin izi fɔ tek di mɛrɛsin bikɔs i kin mek dɛn fil pen na dɛn bɔdi, mɔ na di mɔsul dɛn. Sɔm pipul dɛn kin stɔp fɔ tek di mɛrɛsin bikɔs dɛn nɔ kin fil fayn. Dis dɔn apin to yusɛf? If na so i bi, dis atikul go rili impɔtant to yu. Bikɔs, tide wi de tɔk bɔt wan nyu mɛrɛsin we de gi gud protɛkshɔn fɔ di at, we dɛn dɔn introduks to di wan dɛn we nɔ ebul fɔ tek kɔlestrol mɛrɛsin bikɔs ɔf dɛn kayn sayd ɛfɛkt ya.
Wetin na dis nyu drɔg ɛn wetin i de du?
Dɛn kɔl dis nyu mɛrɛsin Bempedoic acid. I kin de ɔnda ɔda nem dɛn na di makit. Dɛn kin gi dis mɛrɛsin mɔ fɔ pipul dɛn we, lɛk aw wi bin dɔn tɔk, kin gɛt sayd ɛfɛkt lɛk pen na dɛn mɔsul dɛn we dɛn de yuz statin drɔgs.
Wan big stכdi we dεn jכs du sho se we yu yuz dis mכ d i de ridyus di bכdi in "bad kכlestכl," כ LDL (low-density lipoprotein) kכlestכl, bay lεk 21% insay 6 mכnt.
Fɔ tɔk am simpul wan, dis bad kɔlɔstrel we dɛn kɔl LDL na in kin de na di wɔl dɛn na wi blɔd vesel dɛn, ɛn smɔl smɔl i kin lɔk dɛn. Jɔs lɛk aw dɔti kin stɔp na wata paip. Dis we aw di blɔd vesel dɛn kin lɔk na in kin mek bɔku bɔku denja sik dɛn lɛk at atak ɛn strok.
So dis nyu mɛrɛsin nɔ jɔs de ridyus di LDL lɛvɛl, bɔt i de ridyus di risk fɔ gɛt at atak bay 23% , ɛn di ɔl risk fɔ gɛt siriɔs kɔndishɔn lɛk at atak, strok, ɔ nid tritmɛnt fɔ blɔd vesel we dɔn blok bay 13%, di stɔdi dɔn kɔnfyus.
So, dis mɛrɛsin bɛtɛ pas di statin dɛn we wi de tek naw?
Dis na di kwɛstyɔn we impɔtant pas ɔl. Sɔntin de we wi ɔl nid fɔ ɔndastand klia wan na ya.
Di ansa na, nɔ . Di bɛst, di bɛst, ɛn fɔs-chɔys klas fɔ drɔgs we de naw na di wɔl fɔ kɔntrol kɔlɔstrel na di statin klas.
So wetin mek dis na nyu drɔg? Tink bɔt am dis we. Statin dεm lεk ‘superhero’ we de lכs kכlestכl. Dis nyu drɔg, Bempedoic acid, tan lɛk da hiro de in ‘smat ɛstɛt.’ As long as di supahiro de roun, wi fit du di wok wi sef. Bɔt sɔntɛnde, pipul dɛn kin de we nɔ kin ebul fɔ bia wit di trɛnk we da hiro de gɛt. Dɛn tɛm dɛn de, i kin bɛtɛ fɔ mek dis smat ɛstɛt ɛp yu pas fɔ nɔ gɛt ɛni prɔtɛkshɔn. Dɔn gɛt am?
Dat min se, if yu dɔktɔ dɔn gi yu wan mɛrɛsin we dɛn kɔl statin, ɛn yu nɔ de gɛt ɛni impɔtant sayd ɛfɛkt, yu fɔ rili kɔntinyu fɔ tek da mɛrɛsin de . Nɔ ivin tink fɔ stɔp yu statin jɔs bikɔs yu gɛt dis nyu mɛrɛsin.
Di rial valyu fɔ dis nyu mɛrɛsin na dat i de gi wan sef ɔda mɛrɛsin fɔ di wan dɛn we de pan risk fɔ gɛt at sik ɛn we nɔ ebul fɔ tek ɛni mɛrɛsin bikɔs ɔf di sayd ɛfɛkt dɛn we statin gɛt.
Lɛ wi jɔs luk wetin di risach dɔn fɛn.
Dis nɔto jɔs smɔl stɔdi. Na wan stɔdi we rili valyu we dɛn du fɔ tri ia, we dɛn yuz wan big grup fɔ pipul dɛn, we na lɛk 14,000, we nɔ bin ebul fɔ tek statin. Lɛ wi luk di men tin dɛn we wi dɔn fɛn na tebul lɛk dis.
| Rizɔlt | Simpul Diskripshɔn |
|---|---|
| Ridyushɔn pan bad kɔlɔstrel (LDL) . | i de ridyus di bad kכlestכl lεvεl bay 21% insay 6 mכnt. |
| Risk fɔ gɛt at atak | I de ridyus di risk fɔ gɛt at atak bay 23%. |
| Ɔl di risk fɔ gɛt at sik | I de ridyus di risk fɔ gɛt siriɔs sik dɛn we de kam pan pɔsin in at lɛk at atak ɛn strok bay 13%. |
| Kɔmpia wit Statin | Statin drɔgs kin wok lɛk tu tɛm fɔ kɔntrol kɔlɔstrel pas Bempedoic acid. |
So udat dis mɛrɛsin rili fayn fɔ?
Dis mɛrɛsin nɔto fɔ ɔlman. I fayn mɔ fɔ dɛn pipul ya:
- Fɔ di wan dɛn we kin gɛt pen we dɛn nɔ kin ebul fɔ bia wit dɛn mɔsul ɔ ɔda tin we nɔ kin izi fɔ dɛn we dɛn de tek statin mɛrɛsin.
- Fɔ di wan dɛn we dɛn dɔktɔ dɔn advays fɔ stɔp fɔ tek statin bikɔs ɔf ɔda bad bad sayd ɛfɛkt dɛn.
- Fɔ di wan dɛn we gɛt ay risk fɔ gɛt at sik if dɛn nɔ kɔntrol dɛn kɔlɔstrel, bɔt we nɔ ebul fɔ tek statin ɔnda ɛnitin.
- If yu dɔn ɔlrɛdi de tek wan statin bɔt yu nid fɔ kɔntrol yu kɔlɔstrel mɔ, yu dɔktɔ go tɛl yuIf yu disayd fɔ ad am as sɛkɔn mɛrɛsin .
De tin wae impɔtant pas ɔl na, nɔr mek ɛni disizhɔn fɔ yusɛf, if yu fɔ tek dis mɛrɛsin ɔr fɔ stɔp fɔ tek statin. Mek shɔ se yu tɔk bɔt dis wit yu dɔktɔ we de trit yu ɛn mek yu disayd jɔs bay in advays.
A bin stɔp fɔ tek statin bifo. A fɔ bigin bak?
Dis na fayn kwɛstyɔn bak. Sɔntɛm yu dɔn gɛt sɔm prɔblɛm wit statin trade ɛn yu dɔn stɔp fɔ tek am. Bɔt di ɛkspɛkt opinion na dat i fayn fɔ stat statin bak, if i pɔsibul, ɔnda mɛrɛsin advays, bifo yu go to ɔda tin dɛn lɛk Bempedoic acid. Bikɔs, lɛk aw wi bin dɔn tɔk bifo tɛm, di sef ɛn bɛnifit dɛn we statin gɛt pas ɔl.
Yu dɔktɔ kin ebul fɔ chenj yu to difrɛn kayn statin ɔ chenj di doz. So, if yu bin gɛt prɔblɛm wit yu fɔs statin, tɔk to yu dɔktɔ bɔt dat bak.
Mɛsej we dɛn kin kɛr go na os
- Di bɛst ɛn impɔtant mɛrɛsin fɔ kɔntrol kɔlɔstrel stil na di statin grup fɔ drɔgs. Dɛn gɛt ay levul fɔ sef.
- Bempedoic acid na valyu ɔltɛrnativ to statin, nɔto fɔ tek in ples.
- Dis nyu mɛrɛsin na fɔ pipul dɛm wae nɔr kin ebul fɔ bia wit di sayd ɛfɛkt dɛm wae statin kin gɛt (espɛshali mɔsul pen).
- Bifo yu tek di risk fɔ nɔ tek ɛni mɛrɛsin atɔl, dis mɛrɛsin de gi yu at protɛkshɔn fɔ di wan dɛn we nɔ ebul fɔ tek statin.
- Mek ɛni disizhɔn bɔt di mɛrɛsin we gɛt kɔlɔstrel, ilɛksɛf yu bigin, stɔp, ɔ chenj di mɛrɛsin, wit yu dɔktɔ. Nɔ disayd fɔ du sɔntin yu wan.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt